Literature DB >> 20034566

Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology.

A Raquel Esteves1, Daniela M Arduíno, Russell H Swerdlow, Catarina R Oliveira, Sandra M Cardoso.   

Abstract

Calpain is a ubiquitous calcium-sensitive protease that is essential for normal physiologic neuronal function. However, mitochondrial-mediated-calcium homeostasis alterations may lead to its pathologic activation that jeopardizes neuronal structure and function. Here, we provide evidence to support a role for the involvement of calpain 1 in mitochondrial-induced neurodegeneration in a Parkinson's disease (PD) cellular model. We show that dysfunctional mitochondria increases cytosolic calcium, thereby, inducing calpain activation. Interestingly, its inhibition significantly attenuated the accumulation of alpha-synuclein oligomers and contributed to an increase of insoluble alpha-synuclein aggregates, known to be cytoprotective. Moreover, our data corroborate that calpain-1 overactivation in our mitochondrial-deficient cells promote caspase-3 activation. Overall, our findings further clarify the crucial role of dysfunctional mitochondria in the control of molecular mechanisms occurring in PD brain cells, providing a potentially novel correlation between the degradation of calpain substrates suggesting a putative role of calpain and calpain inhibition as a therapeutic tool in PD. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20034566     DOI: 10.1016/j.nbd.2009.12.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  23 in total

Review 1.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

Review 2.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

Review 3.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

4.  A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease.

Authors:  Daniela M Arduíno; A Raquel Esteves; Russell H Swerdlow; Sandra M Cardoso
Journal:  Methods Mol Biol       Date:  2015

5.  E2F1 in neurons is cleaved by calpain in an NMDA receptor-dependent manner in a model of HIV-induced neurotoxicity.

Authors:  Jacob W Zyskind; Ying Wang; Giyong Cho; Jenhao H Ting; Dennis L Kolson; David R Lynch; Kelly L Jordan-Sciutto
Journal:  J Neurochem       Date:  2014-11-10       Impact factor: 5.372

6.  β Cell-specific increased expression of calpastatin prevents diabetes induced by islet amyloid polypeptide toxicity.

Authors:  Tatyana Gurlo; Safia Costes; Jonathan D Hoang; Jacqueline F Rivera; Alexandra E Butler; Peter C Butler
Journal:  JCI Insight       Date:  2016-11-03

7.  Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.

Authors:  Diogo Martins Branco; Daniela M Arduino; A Raquel Esteves; Diana F F Silva; Sandra M Cardoso; Catarina Resende Oliveira
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

8.  Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness?

Authors:  Diogo Martins-Branco; Ana R Esteves; Daniel Santos; Daniela M Arduino; Russell H Swerdlow; Catarina R Oliveira; Cristina Januario; Sandra M Cardoso
Journal:  Exp Neurol       Date:  2012-08-19       Impact factor: 5.330

9.  The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson's Disease.

Authors:  Daniel Santos; A Raquel Esteves; Diana F Silva; Cristina Januário; Sandra M Cardoso
Journal:  Mol Neurobiol       Date:  2014-09-14       Impact factor: 5.590

10.  SNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone.

Authors:  Varduhi H Knaryan; Supriti Samantaray; Sookyoung Park; Mitsuyoshi Azuma; Jun Inoue; Naren L Banik
Journal:  J Neurochem       Date:  2013-12-16       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.